Lipoic acid for treatment of progressive multiple sclerosis; Results of a phase 2 randomized placebo-controlled trial

Authors
Category Primary study
ConferenceThe 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Year 2024
This article has no abstract
Epistemonikos ID: a125b2355bc52de6e4d1ef865f16e3fca069cc81
First added on: Apr 04, 2026